SCHEMBL5149296

SCHEMBL5149296

CCCOc1ccc(-c2cc(OC)c(OC)c(OC)c2)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 5/20 0.56
PTPN1 P18031 1/20 0.53
PTPN6 P29350 1/20 0.53
MAPT P10636 2/20 0.51
KDM4E B2RXH2 2/20 0.47
APAF1 O14727 1/20 0.47
RECQL P46063 1/20 0.47
CASP6 P55212 1/20 0.47
CACNA1B Q00975 1/20 0.47
APBA1 Q02410 1/20 0.47
MCL1 Q07820 1/20 0.47
CASP8 Q14790 1/20 0.47
NEK2 P51955 3/20 0.46
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46
PDE4C Q08493 2/20 0.46
PDE4D Q08499 2/20 0.46
CFD P00746 1/20 0.46
S1PR3 Q99500 1/20 0.44
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5154648 0.91 PTPN11 (0.60) PTPN11PTPN1PTPN6KDM4EAPAF1
SCHEMBL4603132 0.89 NEK2 (0.56) PTPN11PTPN1PTPN6KDM4EAPAF1
SCHEMBL4602843 0.86 CFD (0.56) MAPTKDM4EAPAF1RECQLCASP6
SCHEMBL5151152 0.85 PTPN11 (0.57) PTPN11PTPN1PTPN6KDM4EAPAF1
SCHEMBL4600813 0.84 PTGES (0.52) PTPN11PTPN1PTPN6KDM4EAPAF1
SCHEMBL4601815 0.84 PTPN11 (0.62) PTPN11PTPN1PTPN6KDM4ECFD
SCHEMBL4601780 0.82 PTPN11 (0.60) PTPN11PTPN1PTPN6CFDS1PR3
SCHEMBL14610880 0.82 PTPN11 (0.51) PTPN11PTPN1PTPN6KDM4EAPAF1
SCHEMBL4601658 0.82 PTPN11 (0.67) PTPN11PTPN1PTPN6MCL1CFD
SCHEMBL4601640 0.81 PTPN11 (0.59) PTPN11PTPN1PTPN6MCL1CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US claimed
US-20070060573-A1 Acyltryptophanols BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060573-A1 Acyltryptophanols FSHR, NPY1R, NPY2R PTPN11 3529/4885PTPN1 3489/4885PTPN6 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.